• HOME
  • FAQs
  • NEWS
  • FULL PRESCRIBING INFORMATION
  • About VETMEDIN
    • Dual-acting inodilator
    • VETMEDIN
      in CHF
    |
  • About CHF|
    • Signs of CHF
    • AVVI
    • DCM
    • Diagnosing CHF
  • Act Now—Use VETMEDIN|
    • CHF treatment
    • Importance of acting now
    • 2009 ACVIM consensus statement
  • VETMEDIN Efficacy|
    • VetSCOPE
    • QUEST
  • Safety and Dosing|
    • Record of safe use
    • Dosage
  • VETMEDIN Programs
  • Signs of CHF
  • AVVI
  • DCM
  • Diagnosing CHF
    • Clinical history
    • Physical examination
    • Cardiac and pulmonary auscultation
    • Thoracic radiographs
    • Additional diagnostic tests

USEFUL LINKS

  • VETMEDIN Full Prescribing
    Information
  • Cardiac Education Group
  • YourDogsHeart.com
  • Boehringer Ingelheim Vetmedica, Inc.
  • American College of Veterinary
    Internal Medicine

Annual physical examination

Performing a thorough annual physical examination on your canine patients provides an excellent opportunity to evaluate dogs for the presence of heart disease. The following factors provide important clues to cardiac status and can help detect congestive heart failure (CHF) in dogs:

  • Weight and body condition: When cardiac disease occurs, cachexia (weight loss) is more likely to indicate CHF.
  • Respiration: Evaluate rate and effort of respiration. Although normal respiratory rates vary depending on breed, temperature, and weight, a presentation at the 2009 ACVIM forum indicated that a resting respiratory rate higher than 35/minute in a dog (at home) is highly suggestive of heart failure. Accuracy can be further improved by determining a baseline respiration rate and watching for subsequent increases in individual dogs. When the resting respiratory rate increases by 25% to 50% or is above 35/minute, a diagnosis of CHF should be considered.
  • Heart rate: CHF causes cardiac output to decrease, which in turn results in an increased heart rate. So, animals with relatively slow or normal heart rates (80 to 120 beats per minute) are less likely to have CHF than those with higher heart rates.
  • Jugular distension: Include examination of the jugular veins. The presence of abnormal jugular pulses (extending more than one-third of the way up the neck) can indicate CHF in dogs.
  • Mucous membranes and skin turgor: Evaluating mucous membranes in a dog provides an indicator of hydration status, peripheral perfusion, and tissue oxygenation.
  • Abdominal distension: Palpate the abdomen to check for abdominal distension, which can be caused by hepatomegaly or ascites.
  • Pulse abnormalities: Identifying arterial pulse abnormalities, such as hypokinetic (small stroke volume), hyperkinetic (large pulse pressure), and pulse deficits (arrhythmias) can help determine if a dog has CHF. Pulse deficits found in the femoral artery while simultaneously auscultating the heartbeat can be indicative of an arrhythmia.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.

Home Site Map Terms of Use Privacy Contact About Boehringer Ingelheim Vetmedica,Inc.
VETMEDIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.
© 2015 Boehringer Ingelheim Vetmedica, Inc.